Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work. Clarapath's SectionStar is the first (pending US launch) all-in-one tissue sectioning and transfer system that dramatically increases capacity, reliability, and consistency while minimizing the need for highly skilled labor. The company is headquartered and runs its medical device development in Hawthorne, NY. It has a CLIA-certified laboratory that serves clinical and non-clinical organizations.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/24/24 | $36,000,000 | Series B-1 |
CU Healthcare Innovation Fund Mayo Clinic Northwell Ventures  Ochsner Health | undisclosed |
